Pidotimod

· Almirall, S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pidotimod, covering 2022-02-02 to 2022-02-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of Pidotimod in Children With Recurrent Respiratory Tract Infections (RRI) [Phase 4]